Douglas Pagán
Director of Finance/CFO at Jnana Therapeutics, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Joanne Kotz | M | - |
Jnana Therapeutics, Inc.
 Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | 7 years |
| Theo Melas-Kyriazi | M | 64 |
KSQ Therapeutics, Inc.
 KSQ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology KSQ Therapeutics, Inc. develops and deploys precision functional genomics to discover therapies that transform patient lives. The company was founded by Tim Wang and is headquartered in Cambridge, MA. | 5 years |
| Joel C. Barrish | M | - |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | 7 years |
| Jonathan Light | M | - | 7 years | |
| Stephen Pacala | M | 67 |
Princeton University
| 32 years |
| Stuart Schreiber | M | - |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | 7 years |
| Brian M. Cali | M | - |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | 6 years |
| Nick Pullen | M | - |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | - |
| Morris Loeb | M | - |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | - |
| Brian Danieli | M | - |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | 3 years |
| Ronald Renaud | M | 55 |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | - |
| Ramnik Xavier | M | 62 |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | 7 years |
| Matthew Hammond | M | 35 |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | - |
| Elaine Jones | M | 69 |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | - |
| Carlo Rizzuto | M | 53 |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | - |
| Raj Padmanabhan | M | - | 9 years | |
| Kevin Kinsella | M | 78 |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | - |
| Randy Brenner | M | 51 | 9 years | |
| Donald Nicholson | M | 67 |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | 5 years |
| Cecilia Elena Rouse | M | 60 |
Princeton University
| 32 years |
| Margarita I. Chavez | F | - |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | - |
| Annie C. Chen | M | - |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Mauney | M | 56 | 3 years | |
| Adam Veness | M | 38 | 7 years | |
| Heidi Hagen | F | 55 | 2 years | |
| William Haskel | M | 63 | - | |
| Christopher Bowden | M | 63 | 4 years | |
| John R. Weber | M | - |
Columbia Business School
Princeton University
| 7 years |
| Timothy Franson | M | 72 | 8 years | |
| Wyche Fowler | M | 83 | 13 years | |
| Benjamin J. Strain | M | - | 3 years | |
| Arif Padaria | M | - |
Columbia Business School
Princeton University
| 4 years |
| George Golumbeski | M | 67 | 7 years | |
| Kristine Peterson | F | 64 | 7 years | |
| John W. James | M | - |
Columbia Business School
Princeton University
| 6 years |
| Geoffrey Rubin | M | - |
Princeton University
| 6 years |
| Robert D. Stock | M | - |
Princeton University
| 4 years |
| Randal Kirk | M | 70 | 7 years | |
| Kevin A. Davis | M | - |
Princeton University
| 4 years |
| Vassilios Niko Nicopoulos | M | - |
Princeton University
| 5 years |
| Francois Lebel | M | 72 | 5 years | |
| Judith N. Steenbergen | M | - | - | |
| Christine R. Coyne | F | 55 | 4 years | |
| Sanjay Kumar Sanghoee | M | - |
Columbia Business School
| 2 years |
| Christopher Taylor | M | - | - | |
| Debra Perelman | F | - |
Columbia Business School
Princeton University
| 7 years |
| Li Zhong Dai | M | 56 |
Princeton University
| 5 years |
| Prakash Raman | M | - |
KSQ Therapeutics, Inc.
KSQ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology KSQ Therapeutics, Inc. develops and deploys precision functional genomics to discover therapies that transform patient lives. The company was founded by Tim Wang and is headquartered in Cambridge, MA. | - |
| Scott Koenig | M | - |
Columbia Business School
Princeton University
| 7 years |
| Marc Conner | M | - |
Princeton University
| 4 years |
| Jolie von Arnim | F | - |
Columbia Business School
Princeton University
| 7 years |
| Wendy Young | M | - |
Princeton University
| 4 years |
| Richard Lim | M | 52 | 4 years | |
| Debra Perelman | F | 50 |
Columbia Business School
Princeton University
| 7 years |
| Drew Deniger | M | 44 | 4 years | |
| Peter Rathjens | M | 65 |
Princeton University
| 4 years |
| Giorgio Caputo | M | 50 |
Columbia Business School
Princeton University
| 7 years |
| Joseph Zakrzewski | M | 60 | 10 years | |
| Peter C. M. McWilliams | M | - |
Princeton University
| 3 years |
| Zuie Chin Huang | M | 58 | 3 years | |
| Christoph H. Westphal | M | 56 | 10 years | |
| Terrence Kearney | M | 69 | 7 years | |
| Jasbir Seehra | M | 68 | 6 years | |
| Elan Ezickson | M | 60 | 2 years | |
| Jonathan A. G. Auerbach | M | 50 |
Columbia Business School
Princeton University
| 8 years |
| Sarah Higgins | F | 48 | - | |
| Anthony Evnin | M | 83 | 10 years | |
| Wylie W. Vale | M | 82 | 9 years | |
| Kevin McLaughlin | M | 67 | 11 years | |
| Rolf K. Hoffmann | M | 64 | 5 years | |
| James Cannon | M | 85 | 14 years | |
| Murray Brennan | M | 84 | 13 years | |
| Clifford A. Smith | M | - |
Princeton University
| 1 years |
| Andrew Hayden O'Brien | M | - |
Princeton University
| 4 years |
| Craig Leighton | M | - |
Princeton University
| 1 years |
| James R. Davis | M | 71 |
Princeton University
| 4 years |
| Brian Crosby | M | - |
Princeton University
| 4 years |
| Robert W. Crow | M | - |
Princeton University
| 3 years |
| Georgios N. Bourtzos | M | - |
Princeton University
| 1 years |
| Robert J. W. Hill | M | - |
Princeton University
| 4 years |
| Jason Kamras | M | - |
Princeton University
| 4 years |
| Bert Cuthbertson | M | - |
Princeton University
| - |
| Peter B. Kellner | M | 54 |
Princeton University
| 4 years |
| Erik J. Schneider | M | - |
Princeton University
| 4 years |
| Stephen Lionel Prince | M | 50 |
Princeton University
| 4 years |
| Matt Drapkin | M | 50 |
Princeton University
| 4 years |
| Steve LeSieur | M | 50 |
Princeton University
| 5 years |
| Derek Stephen Smith | M | 56 |
Princeton University
| 4 years |
| Tim Gong | M | 60 |
Princeton University
| 3 years |
| Daniel Von Kohorn | M | - |
Princeton University
| 4 years |
| Regina M. DeTore Paglia | F | - | 4 years | |
| Stewart L. McDowell | F | - |
Princeton University
| 4 years |
| Scott D. Karchmer | M | - |
Princeton University
| 4 years |
| Cameron Scholvin | M | - |
Princeton University
| 4 years |
| David Bros | M | - |
Princeton University
| 4 years |
| Peter W. Sloan | M | - |
Princeton University
| 4 years |
| Jian Ping Mei | M | 63 |
Princeton University
| 4 years |
| Mei Sheng Zhou | M | 66 |
Princeton University
| 3 years |
| Marty Felesenthal | M | - |
Princeton University
| 4 years |
| John Kole | M | - |
Princeton University
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Douglas Pagán
- Personal Network
